pindolol has been researched along with fluvoxamine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bergeron, R; Blier, P; de Montigny, C | 1 |
| Herremans, AH; Mos, J; Olivier, B; Van Drimmelen, M; Van Hest, A | 1 |
| Bellodi, L; Guglielmo, E; Mundo, E | 1 |
| Benedetti, F; Catalano, M; Di Bella, D; Perez, J; Smeraldi, E; Zanardi, R | 1 |
| Franchini, L; Gasperini, M; Lucca, A; Perez, J; Smeraldi, E; Zanardi, R | 1 |
| Alvarez, E; Artigas, F; Pérez, V; Puigdemont, D; Soler, J | 1 |
| Dannon, PN; Dolberg, OT; Grunhaus, L; Hirschmann, S; Iancu, I; Zohar, J | 1 |
| Daws, LC; Frazer, A; Gerhardt, GA; Gould, GG; Teicher, SD | 1 |
| Nakada, S | 1 |
| Cusin, C; Lilli, R; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R | 1 |
| Cusin, C; Dotoli, D; Franchini, L; Lattuada, E; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R | 1 |
| Cusin, C; Lattuada, E; Lilli, R; Lorenzi, C; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R | 1 |
| Benedetti, F; Colombo, C; Cusin, C; Mandelli, L; Pirovano, A; Serretti, A; Smeraldi, E; Zanardi, R | 1 |
| Daws, LC; Horton, RE; Montañez, S; Munn, JL; Owens, WA | 1 |
1 review(s) available for pindolol and fluvoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 trial(s) available for pindolol and fluvoxamine
| Article | Year |
|---|---|
Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Pindolol; Psychiatric Status Rating Scales; Serotonin Antagonists; Time Factors | 1998 |
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
Topics: Antidepressive Agents, Second-Generation; Carrier Proteins; Depressive Disorder; Drug Therapy, Combination; Female; Fluvoxamine; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Pindolol; Polymorphism, Genetic; Predictive Value of Tests; Promoter Regions, Genetic; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins | 1998 |
Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Fluvoxamine; Hemodynamics; Humans; Male; Middle Aged; Pindolol; Serotonin Antagonists; Treatment Outcome | 1998 |
A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
Topics: Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Pindolol; Placebos; Selective Serotonin Reuptake Inhibitors; Single-Blind Method | 1999 |
Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Anti-Anxiety Agents; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Pindolol; Psychiatric Status Rating Scales | 2000 |
Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.
Topics: Adult; Age of Onset; Alleles; Antidepressive Agents, Second-Generation; Bipolar Disorder; Carrier Proteins; Delusions; Depressive Disorder; Drug Synergism; Female; Fluvoxamine; Genetic Variation; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Pindolol; Polymerase Chain Reaction; Predictive Value of Tests; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase | 2001 |
Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Carrier Proteins; Delusions; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluvoxamine; Genetic Variation; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Pindolol; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2001 |
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Antimanic Agents; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Female; Fluvoxamine; Genotype; Humans; Lithium; Male; Middle Aged; Monoamine Oxidase; Paroxetine; Pindolol; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sex Characteristics | 2002 |
Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism.
Topics: Adult; Aged; Antidepressive Agents; CLOCK Proteins; Double-Blind Method; Drug Therapy, Combination; Female; Fluvoxamine; Gene Frequency; Genotype; Humans; Male; Middle Aged; Mood Disorders; Multivariate Analysis; Paroxetine; Pindolol; Polymorphism, Genetic; Serotonin Antagonists; Sleep Initiation and Maintenance Disorders; Time Factors; Trans-Activators; Treatment Outcome | 2005 |
11 other study(ies) available for pindolol and fluvoxamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Buspirone; Depressive Disorder; Desipramine; Drug Synergism; Female; Fluvoxamine; Humans; Male; Pindolol; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Trimipramine | 1997 |
The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Columbidae; Discrimination Learning; Fluvoxamine; Indoles; Pindolol; Piperazines; Pyridines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 1997 |
5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo.
Topics: Animals; Binding, Competitive; Dose-Response Relationship, Drug; Drug Synergism; Electrochemistry; Extracellular Space; Fenclonine; Fluvoxamine; Hippocampus; Male; Metabolic Clearance Rate; Microinjections; Pindolol; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2000 |
[Effects of (+/-)-pindolol over increased extracellular 5-HT level induced by fluvoxamine: regional difference in effect among the raphe, dorsal hippocampus and prefrontal cortex as measured by in vivo microdialysis technique].
Topics: Animals; Autoreceptors; Drug Synergism; Extracellular Space; Fluvoxamine; Hippocampus; Male; Microdialysis; Pindolol; Prefrontal Cortex; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin | 2000 |
5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice.
Topics: Animals; Fluvoxamine; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pindolol; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins | 2014 |